ANANTH ANNAPRAGADA to Rats
This is a "connection" page, showing publications ANANTH ANNAPRAGADA has written about Rats.
Connection Strength
0.292
-
Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
Score: 0.076
-
Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats. Int J Nanomedicine. 2007; 2(3):501-13.
Score: 0.037
-
Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats. J Control Release. 2006 Jun 28; 113(2):117-27.
Score: 0.035
-
Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
Score: 0.033
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.024
-
Full-Thickness Heart Repair with an Engineered Multilayered Myocardial Patch in Rat Model. Adv Healthc Mater. 2017 Mar; 6(5).
Score: 0.019
-
Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. PLoS One. 2009 Jun 09; 4(6):e5843.
Score: 0.011
-
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 2009 Aug; 30(23-24):3986-95.
Score: 0.011
-
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 2009 Feb; 250(2):398-406.
Score: 0.011
-
Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials. 2008 Dec; 29(36):4815-22.
Score: 0.010
-
High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007 Jan; 28(1):48-53.
Score: 0.009
-
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med. 2006 May; 55(5):1023-9.
Score: 0.009
-
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 2003 Sep 19; 92(1-2):49-67.
Score: 0.007